Core Insights - Rapid Micro Biosystems, Inc. is participating in the Stifel 2024 Healthcare Conference, highlighting its role in the life sciences technology sector [1] - The company will have a 30-minute Q&A session on November 18, 2024, featuring its President and CEO, Rob Spignesi, and CFO, Sean Wirtjes [2] Company Overview - Rapid Micro Biosystems specializes in automation solutions for the efficient manufacturing and safe release of healthcare products, including biologics, vaccines, cell and gene therapies, and sterile injectables [3] - The flagship product, Growth Direct system, modernizes microbial quality control testing workflows in pharmaceutical manufacturing, enhancing speed, accuracy, operational efficiency, and compliance with data integrity regulations [3] - The company is headquartered in Lexington, Massachusetts, with manufacturing facilities in Lowell, Massachusetts, and global locations in Switzerland, Germany, and the Netherlands [3]
Rapid Micro Biosystems to Participate in the Stifel 2024 Healthcare Conference